Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Verbist

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Acta Clinica Belgica|January 1, 1980
New beta-lactam antibioticsL Verbist
Pharmaceutisch Weekblad. Scientific Edition|December 11, 1987
In vitro activity and mode of action of fluoroquinolonesL Verbist
Pharmaceutisch Weekblad. Scientific Edition|February 21, 1986
Quinolones: pharmacologyL Verbist
The Journal of Antimicrobial Chemotherapy|September 1, 1987
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinoloneL Verbist
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1993
Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study GroupL Verbist
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1993
Relevance of antibiotic susceptibility testing for clinical practiceL Verbist
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1991
Incidence of multi-resistance in gram-negative bacterial isolates from intensive care units in Belgium: a surveillance studyL Verbist
Acta Clinica Belgica|January 1, 1985
Multicenter in vitro study of piperacillinL Verbist
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996
In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolatesL Verbist, J Verhaegen
Praxis Der Pneumologie|May 1, 1972
[Has the intermittent therapy of pulmonary tuberculosis a future in industrialised countries?]A Gyselen, L Verbist
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Acta Clinica Belgica|January 1, 1980
New beta-lactam antibioticsL Verbist
Pharmaceutisch Weekblad. Scientific Edition|December 11, 1987
In vitro activity and mode of action of fluoroquinolonesL Verbist
Pharmaceutisch Weekblad. Scientific Edition|February 21, 1986
Quinolones: pharmacologyL Verbist
The Journal of Antimicrobial Chemotherapy|September 1, 1987
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinoloneL Verbist
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1993
Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study GroupL Verbist
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1993
Relevance of antibiotic susceptibility testing for clinical practiceL Verbist
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1991
Incidence of multi-resistance in gram-negative bacterial isolates from intensive care units in Belgium: a surveillance studyL Verbist
Acta Clinica Belgica|January 1, 1985
Multicenter in vitro study of piperacillinL Verbist
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996
In vitro activity of trovafloxacin versus ciprofloxacin against clinical isolatesL Verbist, J Verhaegen
Praxis Der Pneumologie|May 1, 1972
[Has the intermittent therapy of pulmonary tuberculosis a future in industrialised countries?]A Gyselen, L Verbist
Pageof 16